Devyser has been awarded a tender for Devyser RHD, its product for non-invasive fetal RHD status in...
“Devyser is reporting record sales growth (+50% organic growth) for the third quarter, a further...
Dear Devyser network, partners, and valued customers,
Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote...
Devyser and Thermo Fisher Scientific have agreed to expand commercial collaboration by including...
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Devyser has inaugurated its CLIA-certified laboratory in Atlanta, Georgia. The laboratory will...
Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA...
Fetal derived cell-free DNA (cfDNA) is a key analyte for determining fetal RHD status in plasma...
Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted...
“The first quarter of the year saw continued strong growth, record gross margin and the launching...
Devyser is today announcing that the company’s clinical testing laboratory in Roswell in Atlanta,...
